Literature DB >> 11055196

[Cerebral circulation in different types of brain hypoxia].

I V Gannushkina.   

Abstract

The paper describes differences of hypoxic and circulatory hypoxias (i.e. brain ischemia) which cause decreases not only in the supply of O2, but in the delivery of glucose and other oxidation substrates and in venous return, which is attended by the accumulation of metabolic products in the brain tissue. It also considers the mechanisms of primary and secondary brain ischemia occurring with decreased cerebral circulation due to breakdown of cerebral blood flow autoregulation at its lower and upper borders to develop cytotoxic or vasogeneous brain tissue edema with possible compression of the microcirculatory bed in the latter case. Emphasis is laid on the significance of autoimmune reactions occurring with the impaired blood-brain barrier due to different types of cerebral circulatory disorders, which gives an insight into the cause of progressive damage to the brain in some cases despite its single damage. The paper outlines current therapies for brain ischemia, including those that exert effects on metabolic disturbances and neurosurgical reparative operations. In conclusion, the paper considers a new nontraditional way of increasing collateral CBF by decreasing blood flow pseudoturbulence with special high molecular-weight linear polymer solutions by the Thoms-effect method (1948). The prospects for using this approach in patients with brain ischemia are substantiated by a number of the established facts: 1) the above patients have higher hemodynamic blood flow resistance which may be corrected by adding a polymer solution into the sample in in vitro tests; 2) there was an inverse relationship of the intrinsic plasma concentrations of high molecular-weight fragments of DNA and hemodynamic resistance to the changes in plasma DNA properties in stroke patients.

Entities:  

Mesh:

Year:  2000        PMID: 11055196

Source DB:  PubMed          Journal:  Vestn Ross Akad Med Nauk        ISSN: 0869-6047


  3 in total

1.  Inhibition of 15-lipoxygenase (15-LOX) reverses hypoxia-induced down-regulation of potassium channels Kv1.5 and Kv2.1Inhibition of 15-lipoxygenase (15-LOX) reverses hypoxia-induced down-regulation of potassium channels Kv1.5 and Kv2.1.

Authors:  Wenjuan Liu; Di Wang; Kaibin Song; Li Chen; Yanmei Zhu; Peifang Liu; Yulan Zhu
Journal:  Int J Clin Exp Med       Date:  2014-11-15

2.  Urokinase-Type Plasminogen Activator Enhances the Neuroprotective Activity of Brain-Derived Neurotrophic Factor in a Model of Intracerebral Hemorrhage.

Authors:  Stalik Dzhauari; Svetlana Litvinova; Anastasia Efimenko; Natalia Aleksandrushkina; Nataliya Basalova; Maxim Abakumov; Natalia Danilova; Pavel Malkov; Vadim Balabanyan; Tatiana Bezuglova; Viktor Balayants; Maxim Mnikhovich; Mikhail Gulyaev; Mariya Skryabina; Vladimir Popov; Dmitry Stambolsky; Tatiana Voronina; Vsevolod Tkachuk; Maxim Karagyaur
Journal:  Biomedicines       Date:  2022-06-08

3.  MSC Secretome as a Promising Tool for Neuroprotection and Neuroregeneration in a Model of Intracerebral Hemorrhage.

Authors:  Maxim Karagyaur; Stalik Dzhauari; Nataliya Basalova; Natalia Aleksandrushkina; Georgy Sagaradze; Natalia Danilova; Pavel Malkov; Vladimir Popov; Mariya Skryabina; Anastasia Efimenko; Vsevolod Tkachuk
Journal:  Pharmaceutics       Date:  2021-11-29       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.